High relative risk of all-cause mortality attributed to smoking in China: Guangzhou Biobank Cohort Study by Lam, Tai Hing et al.
 
 
University of Birmingham
High relative risk of all-cause mortality attributed to
smoking in China: Guangzhou Biobank Cohort
Study
Lam, Tai Hing; Xu, Lin; Jiang, Chao Qiang; Zhang, Wei Sen; Zhu, Xiao-Feng; Jin, Ya Li;
Thomas, G Neil; Cheng, Kar
DOI:
10.1371/journal.pone.0196610
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Lam, TH, Xu, L, Jiang, CQ, Zhang, WS, Zhu, X-F, Jin, YL, Thomas, GN & Cheng, K 2018, 'High relative risk of
all-cause mortality attributed to smoking in China: Guangzhou Biobank Cohort Study', PLoS ONE, vol. 13, no. 4,
e0196610. https://doi.org/10.1371/journal.pone.0196610
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
RESEARCH ARTICLE
High relative risk of all-cause mortality
attributed to smoking in China: Guangzhou
Biobank Cohort Study
Tai Hing Lam1‡, Lin Xu2‡, Chao Qiang Jiang3*, Wei Sen Zhang3, Feng Zhu3, Ya Li Jin3, G.
Neil Thomas4, Kar Keung Cheng4
1 School of Public Health, the University of Hong Kong, Hong Kong SAR, China, 2 School of Public Health,
Sun Yat-sen University, Guangzhou, China, 3 Guangzhou No.12 Hospital, Guangzhou, China, 4 Institute of
Applied Health Research, University of Birmingham, Birmingham, United Kingdom
‡ These authors are joint first authors on this work.
* cqjiang@hku.hk
Abstract
Background
Prediction of disease burden in China arising from smoking based on earlier cohorts in the
West and China could not reflect the disease burden at the current stage accurately. No
cohort studies in China focused specifically on people born since 1950. We examined the
risk of all-cause mortality attributed to smoking in adults in Guangzhou, the city with the
most rapidly expanding economy in China.
Methods and findings
This population-based prospective cohort included 21,658 women and 8,284 men aged 50+
years enrolled from 2003–2008 and followed until January 2016. During an average follow-
up of 8.8 (standard deviation = 1.8) years, 2,986 (1,586 women, 1,400 men) deaths were
recorded. After adjustment for confounders, the hazards ratios (95% confidence interval
(CI)) of all-cause mortality in current versus never smokers increased from 1.61 (95% CI
1.45–1.80) in those born in 1920–1939 to 2.02 (95% CI 1.74–2.34), and 4.40 (95% CI 3.14–
6.17), in those born in the 1940s and 1950s, respectively (P for trend 0.009).
Conclusions
In smokers born after 1949 in Guangzhou and other areas which have the longest history of
smoking, the mortality risk could have reached three fold that of non-smokers, as in the UK,
US and Australia. If confirmed, unless China quickly and strictly complies with the WHO
Framework Convention on Tobacco Control with massive smoking cessation in the popula-
tion, this is a more striking warning that China will be facing an even larger disease burden
from tobacco use than previous forecasts.
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Introduction
Globally, the tobacco epidemic, which refers to an epidemic of tobacco induced mortality and
mortality that started with increasing tobacco consumption during the past decades, continues
to expand with increasing risk and disease burden especially in middle and low income coun-
tries. Previous cohort studies in the early stages of the tobacco epidemic showed consistent
under-estimation of mortality risks for cohorts in later stages [1]. Cohort studies a few decades
ago from the US and UK observed a two-fold risk of all-cause mortality in smokers relative to
non-smokers (i.e. a relative risk (RR) of two). Whilst the prevalence of smoking in these coun-
tries has been declining, their RR of mortality in smokers has increased to three (i.e., RR = 3.0,
95% confidence interval (CI) 2.9–3.1, and 3.0, 95% CI 2.7–3.3, respectively) [2, 3], which has
also been shown in a recent cohort study in Australia (RR = 3.0, 95% CI 2.7–3.3) [4].
China is considered to be at an earlier stage of the tobacco epidemic [5, 6]. However, emerg-
ing evidence has indicated that China may pass through the early stage of epidemic more rap-
idly, than previous forecasts, with the RR of smoking-induced mortality approaching that in
the West. Chen et al. comparing the RR in two China nationwide cohorts revealed that the
1991 cohort showed a lower RR but the other cohort, the China Kadoorie Biobank (CKB),
with participants recruited in 2004–8 showed a greater RR of 1.65 (95% confidence interval
(CI) 1.59–1.73) in urban men and 1.51 (95% CI 1.40–1.63) in women [7]. Such estimations of
relative risk that are approaching two as in the West [8], were close to that reported earlier in a
small cohort in 1976 in Xi’an, China [9]. The CKB was large, but did not include the largest
and most economically developed cities such as Beijing, Shanghai and Guangzhou. Cohorts
set up more than20 years ago from Beijing and Shanghai showed an elevated mortality risk of
20–40% from smoking, which may represent underestimates for the more recent cohorts in
China [10, 11].
The People’s Republic of China (PRC) was inaugurated in October 1949. Since the1980s,
the economic reform has transformed China from one of the world’s poorest country through
the world’s most rapid economic development to the second largest global economy. This has
been mirrored by a rapidly increasing prevalence of smoking and cigarette consumption
mainly in men. As described above, cohort studies on people mostly born before 1950 may
show under-estimates of smoking-induced mortality risk and could not assess the rapidly
increasing risk because smokers born since 1950 had started smoking cigarettes younger and
smoked more [7]. Guangzhou’s economic development, urbanization and westernisation have
been the fastest, and the tobacco epidemic could be in the most advanced stage in mainland
China, forewarning what may soon happen to the country as a whole. We examined the associ-
ation of smoking, with a focus on those born since 1950, with mortality in older residents in
Guangzhou.
Materials and methods
Study subjects
All participants of the Guangzhou Biobank Cohort Study (GBCS) were recruited from 2003 to
2008. Details of the GBCS have been reported previously [12, 13]. Briefly, the GBCS is a 3-way
collaboration among Guangzhou 12th Hospital and the Universities of Hong Kong and Bir-
mingham, UK. Recruitment of participants was from “The Guangzhou Health and Happiness
Association for the Respectable Elders” (GHHARE), a community social and welfare organiza-
tion. GHHARE is unofficially aligned with the municipal government. Membership is open to
Guangzhou permanent residents aged 50 years (born after 1910) or above for a nominal fee of
4 CNY (50 US cents) per month. GHHARE included about 7% of Guangzhou residents in
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this age group, with branches in all 10 districts of Guangzhou, the capital city of Guangdong
province in southern China. The baseline examination included a face-to-face computer assis-
ted interview by trained nurses on lifestyle, family and personal medical history and assess-
ment of anthropometrics, blood pressure, fasting plasma glucose, lipids and inflammatory
markers. The Guangzhou Medical Ethics Committee of the Chinese Medical Association
approved the study and all participants gave written, informed consent before participation.
Exposure variable and potential confounders
Exposure variable was smoking, defined as having smoked at least one cigarette per day or 7
cigarettes per week for at least half a year. “Current smoker” was defined by answering “yes” to
the question: “Do you smoke cigarettes now?” “Former smoker” was defined as “used to
smoke but not smoking currently”. The reliability of the questionnaire was tested in 200 sub-
jects with Kappa values of 0.88 and 0.96 for the two questions about smoking status, respec-
tively [14].
Potential confounders included age (5-year age group), education (primary school or
below, secondary school, and college or above), occupation (manual, non-manual and others),
family income (<10,000, 10,000–29,999, 30,000–49,999,50,000, and don’t know), physical
activity assessed by the Chinese version of International Physical Activity Questionnaire (inac-
tive, moderately active and physically active), alcohol drinking (never, former and current
drinkers), self-rated health (very good, good, poor and very poor) and sex. Self-rated health
was determined by the question: “In general do you think your health is very good, good, poor
or very poor?” Since very few (1.6%) participants selected the extreme categories, “very good”
or “very poor”, this variable was dichotomized into good (including “very good” and “good”)
and poor (including “very poor” and “poor”). Occupation was assessed from participants’ lon-
gest-held occupation, categorized as manual (including the original “agricultural work”, “fac-
tory work”, or “sales and services”), non-manual (originally “administrative/managerial”,
“professional/technical”, or “military/police”) and others. The correlation among the socioeco-
nomic variables were weak (correlation coefficients ranged from 0.05 to 0.18), thus multicoli-
nearity should not be a concern in our model.
Mortality. Information on underlying causes of deaths up to January 2016 was mostly
obtained via record linkage with the Guangzhou Center for Disease Control and Prevention
(GCDC). When participants were confirmed dead but the exact dates of death were not avail-
able, the mid-point between the date of recruitment and 31 January 2016 was used (n = 6).
Statistical analysis
Chi-square tests or analysis of variance were used to compare participants’ baseline character-
istics by smoking status. The Cox proportional assumption was checked using Schoenfeld
residuals by “stphtest” command in STATA. As no evidence of violation for the proportional
hazard assumption was found, the Cox proportional hazards model was used to calculate
adjusted hazard ratios (HRs) with 95% CI. Group specific CI for the non-smokers HR of 1.00
was calculated to reflect the variance of the log risk in non-smokers using Plummer’s Method
[15]. Participants who died of any other causes were regarded as censored at the date of death
[16, 17]. For those who were alive, as registered by the police, they were right-censored on 31
January 2016. We stratified the cohort into those born in 1920–1939, 1940s and 1950s (range:
1950–1957) for analysis of all-cause mortality. We firstly conducted the analysis for each birth
cohort, and then for all participants including all three birth cohorts, in men and women sepa-
rately and combined.
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The population attributable risk (PAR) was calculated using the following equation (in
which PAR denotes the population attributable risk, P the proportion of smokers, and RR rela-
tive risk): PAR = P(RR−1)/[P(RR−1)+1]. The relative risk or PAR of death associated with
smoking was calculated based on HRs in men and women separately. When the event rate is
low, the PAR calculated by HR agrees with the approximation obtained using the standard
PAR formula (i.e., using RR), which is consistent with the rare disease assumption commonly
used to justify that the risk ratio and hazard ratio are equivalent when a disease is rare [18].
Information on the prevalence of smoking was obtained according to the Global Adult
Tobacco Survey China 2010 Country Report (http://www.who.int/tobacco/surveillance/
survey/gats/zh_gats_china_report.pdf, accessed on online on July 4th, 2016). The numbers of
deaths attributable to smoking in men and women were then calculated by multiplying the
PARs according to the relative mortality risk from the study and 2010 Population Census from
the National Bureau of Statistics of China (http://www.stats.gov.cn/english/statisticaldata/
censusdata/, accessed online on July 4th, 2016). All analysis was performed in STATA/IC 13.1.
Results
Of the 30,430 participants at baseline, 391 were excluded because of loss to follow-up with
unknown vital status and 97 excluded because of incomplete information on smoking, giving
29,942 participants (21,658 women and 8,284 men) in this paper. The mean age was 62 years
(standard deviation (SD) = 7.1) years. During the average follow-up of 8.8 years (SD = 1.8),
2,986 (women 1,586 (7.3%) and men 1,400 (16.9%)) deaths were recorded.
In men, 60.3% were ever smokers. Relative to never smokers, ever smokers were younger,
had lower socioeconomic position (lower education and income, and manual occupation),
and tended to be physically inactive, but more commonly consumed alcohol. In women, only
3.5% were ever smokers, and, relative to never smokers they were older, had lower socioeco-
nomic position and tended to be physically inactive (Table 1).
Table 2 shows that for men and women who born during the 1920–1939, 1940–1949 and
1950–1957, the median (interquartile range) age at death were 77 (6), 67 (5) and 58 (4) years,
respectively (Table 2). Fig 1 shows that, in men, adjusting for age, education, occupation, fam-
ily income, physical activity, alcohol drinking and self-rated health, the HR of all-cause mortal-
ity in ever (current plus former) male smokers versus never smokers increased from 1.59
(1.38–1.84) in those who were born during the 1920–1939, to 1.79 (1.40–2.28) and 3.48 (1.54–
7.83), in those born in the 1940s and 1950s, respectively (p for trend 0.02). A similar trend was
observed in women, from 1.23 (1.004–1.52) to 1.74 (1.11–2.72), then to 4.80 (1.74–13.28),
respectively (p for trend 0.12). Although women tended to show higher HR, we found no evi-
dence that the risks varied by sex (p for sex interaction from 0.08 to 0.88). Pooling men and
women together and further adjusting for sex, the HR was 4.40 (3.14–6.17) in current smokers
born since 1950 (P<0.001). Former smokers showed consistently lower HR than current
smokers in men and in women. Further sub-group analyses were not performed due to small
numbers.
Discussion
In this cohort study of older Chinese who underwent the most advanced stage of tobacco epi-
demic in mainland China, we observed in all participants increasing mortality risk in ever
smokers versus never smokers from 1.49 in those born in1920-1939, to 3.87 in those born
since1950. Because of the risk reduction from quitting, HR for ever smoking would under-esti-
mate the risk associated with smoking. In current smokers, the HR of 4.40 (95% CI 3.14–6.17)
was very high, but the lower limit of the 95% CI of 3.14 supports that the HR in men has
High relative risk of all-cause mortality from smoking in China
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reached a level well over three. Such a large relative risk observed in the lower limit of the 95%
CI has never been reported in Chinese cohorts previously. The CKB also showed that the few
urban men who had started smoking before the age of 15 years were at even greater risk (RR
2.64, 95% CI 2.19–3.19) [7]. Hence, our relative risk of greater than three in a cohort born
more recently is quite plausible. Our results further suggest that the tobacco epidemic could
have reached a more advanced stage in Guangzhou than other places of China reported in the
CKB and possibly the rest of mainland China [7, 10, 19–21].
Guangzhou is close (about 120 km) to Hong Kong, which has an advanced stage of tobacco
epidemic [22] and a mortality relative risk of about 2 in people aged 65 years or more [23]. But
Table 1. Baseline characteristics of 21,658 women and 8,284 men aged 50+ in the Guangzhou Biobank Cohort Study first examined in 2003 to 2008 and followed up
until January 2016.
Men Women
Never smokers Ever smokers Never smokers Ever smokers
Number of participants (row %) 3,288 (39.7) 4,996 (60.3) 20,894 (96.5) 764 (3.5)
Age, years, mean (standard deviation) 64.7 (6.6) 64.2 (6.8) 60.9 (7) 67.2 (6.3)
Age group, years, %
50–54 7.6 9.1 23.7 4.7
55–59 17.6 20.8 27.7 9.4
60–64 25.8 24.4 19.1 18
65–69 26.1 23.6 17.3 32.7
70–74 17.6 17.2 9.5 27.8
75–79 4.1 4 2.2 5.2
80+ 1.2 0.9 0.5 2.1
Education, %
Primary or below 22.3 35.1 46.7 79.3
Secondary 53.6 52.6 47.3 19.9
College or above 24.2 12.3 6 0.8
Occupation, %
Manual 41.6 51.7 65.7 79.3
Non-manual 43.5 34 18.7 11.7
Others 14.9 14.3 15.6 9
Family income, CNY/year, %
<10,000 3.6 5.5 5.9 12.3
10,000–29,999 32.2 34.9 31.3 39.5
30,000–49,999 23.1 21.4 21.3 10.2
50,000 21.9 16.1 16.8 6.6
Don’t know 19.2 22 24.7 31.5
Physical activity, %
Inactive 7.5 9 8 5.9
Minimally active 43.3 45.8 39.3 43.4
Active 49.2 45.2 52.6 50.7
Alcohol use, %
Never 65.1 46.8 79.6 70.7
Former 3.8 7.8 2.4 5
Current 31.2 45.5 18 24.4
Poor health status, %
No 87.1 83.4 81.2 79.9
Yes 12.9 16.6 18.8 20.1
https://doi.org/10.1371/journal.pone.0196610.t001
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participants of the Hong Kong cohort were recruited in 1998–2001 and born in the 1930s [23,
24]. In mainland China, the relative mortality risk in the CKB (1.65) and most of the earlier
cohorts were lower than 2 [10, 11, 19–21, 25]. A notable exception was a small cohort of 1,696
factory workers in Xi’an, which showed a relative risk of 2.42 (95% CI 1.72–3.42) in men and
2.32 (95% CI 1.18–4.56) in women for ever versus never smokers after a very long mean fol-
low-up of 20 years [9]. However, the lower limits of the 95% CI were below two. Studies with
longer follow up would yield greater relative risks, as shown clearly by the British Doctors
Cohort Study [26, 27]. In the US, where the epidemic has come to the final stage (i.e., stage 4,
the decline in smoking prevalence is evident in this stage), the smoking-related mortality risk
in smokers versus non-smokers has increased to about 3 over the last 50 years [28]. The
increased relative risk in smokers versus non-smokers could be due to the increased incidence
of smoking-related disease and/or reduction in competing risk such as deaths from infectious
disease in the past several decades. Also, the increase life expectancy of people born after the
establishment of People’s Republic of China in October 1949 could have benefited non-smok-
ers much more than persistent smokers starting at younger age, resulting in a widening the
gap of the survival curves and increasing relative risk. New and large cohort studies of people
born since 1950 or post World War II with longer follow-up are needed to assess the increas-
ing risk of mortality associated with smoking in China and elsewhere. The increasing risk and
growing epidemic in other populations, especially in the big cities where the tobacco epidemic
is more advanced, in China and other rapidly developing countries in the next few decades
needs to be closely monitored. Longer follow up of existing cohorts and new cohort studies
including more recently born cohorts will help clarify the picture.
Our focus on those born after the birth of PRC has shown an alarming finding. These peo-
ple had not gone through World War II and the civil war (1946–49), which should imply lon-
ger survival but could be compromised by greater cigarette consumption. The high RR of
premature death in middle age from smoking in this group means that smoking would lead to
premature death, disease and economic burdens very soon and in an unexpectedly large scale
in many middle aged, as well as older people, posing huge challenges to the unprepared health
care and related systems. To estimate absolute numbers of tobacco-attributed deaths in China
in 2010, the smoking-attributed fractions of all deaths in our study have been applied to num-
bers of deaths in men and women separately in mainland China at ages 30 year or older. This
Table 2. Median age at death and person-years (number of deaths) by smoking status and year of birth, in 21,658 women and 8,284 men from the Guangzhou Bio-
bank Cohort Study in 2003–2008 and followed up until January 2016.
Year of birth Age at death (median, IQR), years Person-years (No. of deaths) by smoking status
Never Former Current
Men
1920–1939 77, 6 15343 (309) 11430 (367) 8344 (286)
1940–1949 68, 5 13455 (98) 9218 (111) 11926 (170)
1950–1957 58, 5 3479 (8) 1783 (11) 4074 (37)
Women
1920–1939 77, 6 59173 (924) 2537 (54) 2437 (57)
1940–1949 67, 5 89850 (415) 829 (8) 1285 (16)
1950–1957 58, 3 57511 (103) 158 (1) 267 (3)
Total
1920–1939 77, 6 74516 (1233) 13968 (421) 10782 (343)
1940–1949 67, 5 103306 (513) 10047 (119) 13211 (186)
1950–1957 58, 4 60991 (111) 1942 (12) 4341 (40)
https://doi.org/10.1371/journal.pone.0196610.t002
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Fig 1. Adjusted HR and 95% CI of all-cause mortality for former (ex-), current, and ever (former+ current)
smokers versus never smokers by birth cohorts in men, women and total.
https://doi.org/10.1371/journal.pone.0196610.g001
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shows that there were about 1.5 million smoking-attributed deaths in 2010 (1,360,000 males,
146,000 females; S1 Table), 50% higher than those estimated by the CKB [29]. The numbers
should be higher now (i.e., in 2017). If the current pattern of smoking is sustained, and the
compliance to the Framework Convention on Tobacco Control (World Health Organization’s
first international treaty ratified by almost all countries to address a public health problem)
[30] continues to be lagging behind, China will not be able to meet the United Nations 2030
Sustainable Development Goals (SDG) to reduce premature deaths (before age 70) from non-
communicable diseases (NCDs) by one-third.
Our study has important clinical and public health implications. The World Health Organi-
sation statement that “tobacco kills up to one in every two users” [31] is derived from Peto
based on an RR of two for all-cause mortality from smoking [32]. This statement now appears
to be an under-estimate, at least for countries like the US, UK and Australia, or large cities
such as Guangzhou with an RR over two, and approaching or already three. Translating such
relative risk means that the WHO statement could be revised to “Tobacco kills at least one in
every two, or even two in every three users”. Absolute risk, which means the chance of devel-
oping a disease (or death) during a specified period, is easier to understand than relative risk.
Most smokers and many physicians grossly under-estimate the absolute mortality risks of
smoking. Physicians’ and other health professionals’ warning to their smoking patients,
healthy clients or the public using an absolute risk of at least one out of two, or even as high as
two out of three for high risk smokers could be more striking and effective in motivating more
smokers to quit.
Our results on the benefits in former smokers regardless of the year of birth and sex are
consistent with previous studies in China and elsewhere. Hence, quitting for all smokers in
both sexes respective of age must be the most important action to reduce the death toll. Pool-
ing former and current smokers into ever smokers will underestimate RR. However, excluding
former smokers would under-estimate the absolute attributable numbers or burden of disease,
as some former smokers will still die from smoking-related conditions and they should thus
still be counted. The benefits of quitting smoking as observed in former smokers are likely
diluted by reverse causality, i.e., some quit directly because of smoking-related illness. Future
studies should enquire about reasons of quitting, due to choice or illness, and examine changes
in smoking behaviour during follow up and subsequent health outcomes.
Our study has other limitations. First, the sample size was relatively small, which limited
detailed subgroup analysis. Second, our sample may not be fully representative of the entire
older population in China and as other population based cohort studies of older people,
women were oversampled. However, within our sample, the participants had fairly similar lev-
els of chronic diseases such as diabetes and hypertension to nationally representative samples
of urban Chinese [12]. Finally, our study of people aged 50 years or older could have underesti-
mated the risk of smoking in the younger populations who start smoking as teenagers and
may thus have higher lifetime cumulative exposure, unless they stop early.
In conclusion, the mortality relative risk could have reached three in smokers born after
1949 in Guangzhou and other areas which have the longest history of smoking, as in the UK,
US and Australia. If confirmed, this is a more striking warning that China will be facing an
even larger public health issue of tobacco deaths than hitherto forecast, unless China quickly
and strictly complies with the Framework Convention on Tobacco Control.
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